As of 2025-10-31, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 21.1x | 17.8x |
| Forward P/E multiples | 12.6x - 27.7x | 16.9x |
| Fair Price | (11.69) - (15.42) | (12.61) |
| Upside | -20600.8% - -27145.4% | -22230.4% |
| Date | EV/EBITDA |